Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.INTA Repositorio Digital del Instituto Nacional de Técnica Aeroespacial
Publication Artículo científico (JournalArticle)

Type III secretion system effectors form robust and flexible intracellular virulence networks

  • Ruano Gallego, D.
  • Sánchez Garrido, J.
  • Kozik, Z.
  • Núñez Berrueco, E.
  • Cepeda Molero, Massiel
  • Mullineaux Sanders, C.
  • Clark, J. N.
  • Slater, S. L.
  • Wagner, N.
  • Glegola Madejska, I.
  • Roumeliotis, T. I.
  • Pupko, T.
  • Fernández, L. Á.
  • Rodríguez Patón, A.
  • Choudhary, J. S.
  • Frankel, G.
INTRODUCTION Infections with many Gram-negative pathogens, including Escherichia coli, Salmonella, Shigella, and Yersinia, rely on the injection of effectors via type III secretion systems (T3SSs). The effectors hijack cellular processes through multiple mechanisms, including molecular mimicry and diverse enzymatic activities. Although in vitro analyses have shown that individual effectors can exhibit complementary, interdependent, or antagonistic relationships, most in vivo studies have focused on the contribution of single effectors to pathogenesis. Citrobacter rodentium is a natural mouse pathogen that shares infection strategies and virulence factors with the human pathogens enteropathogenic and enterohemorrhagic E. coli (EPEC and EHEC). The ability of these pathogens to colonize the gastrointestinal tract is mediated by the injection of effectors via a T3SS. Although C. rodentium infects 31 effectors, the prototype EPEC strain E2348/69 translocates 21 effectors. RATIONALE The aim of this study was to test the hypotheses that, rather than operating individually, the T3SS effectors form robust intracellular networks that can sustain large contractions and that expanded effector repertoires play a role in distinct disease phenotypes and host adaption. RESULTS We tested the effector-network paradigm by infecting mice with >100 C. rodentium effector mutant combinations. First, using machine learning prediction algorithms, we discovered additional effectors, NleN and NleO. We then sequentially deleted effector genes from two distinct starting points to reach sustainable endpoints, which resulted in strains missing 19 unrelated effectors (CR14) or 10 effectors involved in the modulation of innate immune responses in intestinal epithelial cells (IECs) (CRi9). Moreover, we deleted Map and EspF, which target the mitochondria and disrupt tight junctions. Unexpectedly, all strains colonized the colon and activated conserved metabolic and antimicrobial processes in the IECs while eliciting distinct cytokine and immune cell infiltration responses. In particular, although infection with C. rodentium Δmap/ΔespF failed to induce secretion of interleukin-22 (IL-22), CR14 and CRi9 triggered heightened secretion of IL-6 and granulocyte-macrophage colony-stimulating factor (GM-CSF) and of IL-22, interferon-γ (IFN-γ), and IL-17 from colonic explants, respectively. Nonetheless, infection with CR14 or CRi9 induced protective immunity against secondary infections. Although Tir, EspZ, and NleA are essential, other effectors exhibit context-dependent essentiality in vivo. Moreover, C. rodentium expressing the effector repertoire of EPEC E2348/69 failed to efficiently colonize mice. We used curated functional information and our in vivo data to train a machine learning model that predicted values for colonization efficiency of previously uncharacterized mutant combinations. Notably, a mutant with a low predicted value, lacking only nleF, nleG8, nleG1, nleB, and espL, failed to colonize. CONCLUSION Our analysis revealed that T3SS effectors form robust networks, which can sustain substantial contractions while maintaining virulence, and that the composition of the effector network contributes to host adaptation. Alternative effector networks within a single pathogen triggered markedly different immune responses yet induced protective immunity. CR14 did not tolerate any further contraction, which suggests that this network reached its robustness limit with only 12 effectors. As the robustness limits of other effector networks depend on the contraction starting point and the order of the deletions, machine learning models could transform our ability to predict alternative network functions. Together, this study demonstrates the robustness of T3SS effector networks and the ability of IECs to withstand drastic perturbations while maintaining antibacterial functions., The work of T.I.R. and J.S.C. was funded by the CRUK Centre grant with reference no. C309/A25144. N.W. was supported by PhD fellowships from the Manna Center Program for Food Safety and Security at Tel Aviv University and the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University. The work of E. N.-B. was funded by a PhD FPU grant from the Spanish government (FPU2017/04179). A. R.-P. was partially funded by project PID2019-106960GB-I00 (AEI/FEDER, Spain) and by InGEMICS-CM, FSE/FEDER, Comunidad de Madrid Project B2017/BMD-3691. L.A.F. is supported by grant BIO2017-89081-R (AEI/MICIU/FEDER, European Union). G.F. is supported by an MRC program grant (MR/R02671/), a Royal Society grant (IC160080), and a Wellcome Investigator Award (107057/Z/15/Z)., Peerreview
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Artículo científico (JournalArticle)

Programmable modular assembly of functional proteins on Raman-encoded zeolitic imidazolate framework-8 (ZIF-8) nanoparticles as SERS tags

  • DE MARCHI LOURENÇO, Sarah
  • Vázquez Iglesias, Lorena
  • Bodelón González, Gustavo
  • Pérez Juste, Ignacio
  • Fernández, Luis Ángel
  • Pérez Juste, Jorge
  • Pastoriza Santos, Isabel
Zeolitic imidazolate framework-8 (ZIF-8) is a metal organic framework with exceptional intrinsic properties, high tunability, cost effectiveness, and producibility, which has boosted the research development of the field. ZIF-8-based materials have shown high capabilities for multiple purposes as catalysts, capacitors, electrodes, drug delivery systems, or adsorption/separation membranes. Herein, we report the synergistic combination of ZIF-8, plasmonic nanoparticles, and rationally designed protein adaptors and antibodies for fabricating novel surface-enhanced Raman scattering (SERS) tags with enhanced sensing capabilities. The SERS tags consist of Au@Ag core–shell nanorods individually encapsulated within a multifunctional ZIF-8 matrix encoded with Raman reporters. While the role of the plasmonic core is to enhance the Raman, the ZIF-8 traps the Raman active molecules and, more importantly, facilitates the active targeting of the SERS tag surface through the modular assembly with conventional (i.e., immunoglobulins) and recombinant antibodies (i.e., nanobodies) mediated by the specific interaction of Zn2+ with polyhistidine-tagged protein G and SpyCatcher. Evidence of the capabilities of the Au@Ag@ZIF-8 nanotags for the SERS detection of EGFR and CD44 cell surface receptors in vitro illustrates the potential of these optical nanoprobes for imaging and multiplex biodetection. The reported modular assembly approach for the functionalization of ZIF-8 SERS nanotags with different classes of antibodies based on polyhistidine-tagged peptides and protein–protein interactions can not only be applied to the ever-increasing number of reported MOFs structures but also can be further exploited as a universal means for the functionalization of other transition metal surfaces., Agencia Estatal de Investigación | Ref. MAT2016-77809-R, Xunta de Galicia | Ref. ED431C2016-048, Fundación Ramón Areces, Agencia Estatal de Investigación | Ref. BIO2017-89081-R, Universidade de Vigo
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities

  • Timmis, James Kenneth
  • Timmis, James Kenneth
  • Brüssow, Harald
  • Fernández, Luis Ángel
Designed nanobody-linked synthetic consortia for microbiota dysbiosis therapies. A. Nanobodies (Nb) are selected for specific antigens on target bacteria destined for a synthetic therapy consortium that may consist of two (B) or multiple (C) members. For the treatment of dysbiosis co-morbidities requiring two functionally distinct consortia, these may be linked through a common member to generate a single bi-functional microbiota therapy (D)., Agencia Española de Investigación, European Research Council, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system

  • Ruano‑Gallego, David
  • Fraile, Sofía
  • Gutiérrez, Carlos
  • Fernández, Luis Ángel
[Background] The hemolysin (Hly) secretion system of E. coli allows the one-step translocation of hemolysin A (HlyA) from the bacterial cytoplasm to the extracellular medium, without a periplasmic intermediate. In this work, we investigate whether the Hly secretion system of E. coli is competent to secrete a repertoire of functional single-domain VHH antibodies (nanobodies, Nbs), facilitating direct screening of VHH libraries and the purification of selected Nb from the extracellular medium., [Results] We employed a phagemid library of VHHs obtained by immunization of a dromedary with three protein antigens from enterohemorrhagic E. coli (EHEC), namely, the extracellular secreted protein A (EspA), the extracellular C-terminal region of Intimin (Int280), and the translocated intimin receptor middle domain (TirM). VHH clones binding each antigen were enriched and amplified by biopanning, and subsequently fused to the C-terminal secretion signal of HlyA to be expressed and secreted in a E. coli strain carrying the Hly export machinery (HlyB, HlyD and TolC). Individual E. coli clones were grown and induced in 96-well microtiter plates, and the supernatants of the producing cultures directly used in ELISA for detection of Nbs binding EspA, Int280 and TirM. A set of Nb sequences specifically binding each of these antigens were identified, indicating that the Hly system is able to secrete a diversity of functional Nbs. We performed thiol alkylation assays demonstrating that Nbs are correctly oxidized upon secretion, forming disulphide bonds between cysteine pairs despite the absence of a periplasmic intermediate. In addition, we show that the secreted Nb-HlyA fusions can be directly purified from the supernatant of E. coli cultures, avoiding cell lysis and in a single affinity chromatography step., [Conclusions] Our data demonstrate the Hly secretion system of E. coli can be used as an expression platform for screening and purification of Nb binders from VHH repertories., We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).Work in the lab of LAF is partially supported by the Grants BIO2017-89081-R (Agencia Española de Investigación AEI/MICIU/FEDER, EU), ERC-2012-ADG_20120314 (European Research Council, EU) and LCCM_P59474 (Wellcome Trust, UK)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9

  • Álvarez, Beatriz
  • Mencía, Mario
  • Lorenzo, Víctor de
  • Fernández, Luis Ángel
© The Author(s) 2020., In vivo mutagenesis systems accelerate directed protein evolution but often show restricted capabilities and deleterious off-site mutations on cells. To overcome these limitations, here we report an in vivo platform to diversify specific DNA segments based on protein fusions between various base deaminases (BD) and the T7 RNA polymerase (T7RNAP) that recognizes a cognate promoter oriented towards the target sequence. Transcriptional elongation of these fusions generates transitions C to T or A to G on both DNA strands and in long DNA segments. To delimit the boundaries of the diversified DNA, the catalytically dead Cas9 (dCas9) is tethered with custom-designed crRNAs as a “roadblock” for BD-T7RNAP elongation. Using this T7-targeted dCas9-limited in vivo mutagenesis (T7-DIVA) system, rapid molecular evolution of the antibiotic resistance gene TEM-1 is achieved. While the efficiency is demonstrated in E. coli, the system can be adapted to a variety of bacterial and eukaryotic hosts., This work was supported by the Grants BIO2017-89081-R (Agencia Española de Investigación AEI/MICIU/FEDER, EU) to L.A.F. and ERC-2012-ADG_20120314– (European Research Council,EU) to V.d.L.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Programmable Modular Assembly of Functional Proteins on Raman-Encoded Zeolitic Imidazolate Framework-8 (ZIF-8) Nanoparticles as SERS Tags

  • Marchi, Sarah De
  • Vázquez-Iglesias, Lorena
  • Bodelón, Gustavo
  • Pérez-Juste, Ignacio
  • Fernández, Luis Ángel
  • Pérez-Juste, Jorge
  • Pastoriza-Santos, Isabel
Zeolitic imidazolate framework-8 (ZIF-8) is a metal organic framework with exceptional intrinsic properties, high tunability, cost effectiveness, and producibility, which has boosted the research development of the field. ZIF-8-based materials have shown high capabilities for multiple purposes as catalysts, capacitors, electrodes, drug delivery systems, or adsorption/separation membranes. Herein, we report the synergistic combination of ZIF-8, plasmonic nanoparticles, and rationally designed protein adaptors and antibodies for fabricating novel surface-enhanced Raman scattering (SERS) tags with enhanced sensing capabilities. The SERS tags consist of Au@Ag core–shell nanorods individually encapsulated within a multifunctional ZIF-8 matrix encoded with Raman reporters. While the role of the plasmonic core is to enhance the Raman, the ZIF-8 traps the Raman active molecules and, more importantly, facilitates the active targeting of the SERS tag surface through the modular assembly with conventional (i.e., immunoglobulins) and recombinant antibodies (i.e., nanobodies) mediated by the specific interaction of Zn2+ with polyhistidine-tagged protein G and SpyCatcher. Evidence of the capabilities of the Au@Ag@ZIF-8 nanotags for the SERS detection of EGFR and CD44 cell surface receptors in vitro illustrates the potential of these optical nanoprobes for imaging and multiplex biodetection. The reported modular assembly approach for the functionalization of ZIF-8 SERS nanotags with different classes of antibodies based on polyhistidine-tagged peptides and protein–protein interactions can not only be applied to the ever-increasing number of reported MOFs structures but also can be further exploited as a universal means for the functionalization of other transition metal surfaces., This work was supported by the Ministerio de Economıa y Competitividad (MINECO; Spain, grant MAT2016-77809-R), Xunta de Galicia/FEDER (grant GRC ED431C 2016-048), Fundación Ramón Areces (SERSforSafety), FOODSENS cofunded by FEDER through the program Interreg V-A España-Portugal (POCTEP) 2014−2020, and the European Union (European Regional Development Fund, ERDF). The work in the laboratory of L.A.F. was supported by grant BIO2017-89081-R (Agencia Española de Investigacion AEI/ ́ MICIU/FEDER, EU). S.M. acknowledges the support from CsF/CNPq-Brazil fellowship. G.B. acknowledges the support from the CINBIO fellowship.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Enteropathogenic Escherichia coli Stimulates Effector-Driven Rapid Caspase-4 Activation in Human Macrophages

  • Goddard, Philippa J.
  • Sanchez-Garrido, Julia
  • Slater, Sabrina L.
  • Kalyan, Mohini
  • Ruano-Gallego, David
  • Marchès, Olivier
  • Fernández, Luis Ángel
  • Frankel, Gad
  • Shenoy, Avinash R.
© 2019 The Author(s)., Microbial infections can stimulate the assembly of inflammasomes, which activate caspase-1. The gastrointestinal pathogen enteropathogenic Escherichia coli (EPEC) causes localized actin polymerization in host cells. Actin polymerization requires the binding of the bacterial adhesin intimin to Tir, which is delivered to host cells via a type 3 secretion system (T3SS). We show that EPEC induces T3SS-dependent rapid non-canonical NLRP3 inflammasome activation in human macrophages. Notably, caspase-4 activation by EPEC triggers pyroptosis and cytokine processing through the NLRP3-caspase-1 inflammasome. Mechanistically, caspase-4 activation requires the detection of LPS and EPEC-induced actin polymerization, either via Tir tyrosine phosphorylation and the phosphotyrosine-binding adaptor NCK or Tir and the NCK-mimicking effector TccP. An engineered E. coli K12 could reconstitute Tir-intimin signaling, which is necessary and sufficient for inflammasome activation, ruling out the involvement of other virulence factors. Our studies reveal a crosstalk between caspase-4 and caspase-1 that is cooperatively stimulated by LPS and effector-driven actin polymerization., The authors would like to acknowledge grants from the Wellcome Trust (to G.F. and A.R.S.) and the MRC (to P.J.G., G.F., A.R.S., and the CMBI). Work in the laboratory of L.A.F. is funded by grant BIO2017-89081R from the Spanish Ministerio de Ciencia y Universidad (MICIU; AEI/FEDER, EU). G.F. and A.R.S. would like to acknowledge the MRC-funded High-Throughput Single-Cell Analysis facility at the CMBI.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Whole-cell biosensor with tunable limit of detection enables low-cost agglutination assays for medical diagnostic applications

  • Kylilis, Nicolas
  • Riangrungroj, Pinpunya
  • Lai, Hung-En
  • Salema, Valencio
  • Fernández, Luis Ángel
  • Stan, Guy-Bart V.
  • Freemont, Paul
  • Polizzi, Karen M.
Whole-cell biosensors can form the basis of affordable, easy-to-use diagnostic tests that can be readily deployed for point-of-care (POC) testing, but to date the detection of analytes such as proteins that cannot easily diffuse across the cell membrane has been challenging. Here we developed a novel biosensing platform based on cell agglutination using an E. coli whole-cell biosensor surface-displaying nanobodies which bind selectively to a target protein analyte. As a proof-of-concept, we show the feasibility of this design to detect a model analyte at nanomolar concentrations. Moreover, we show that the design architecture is flexible by building assays optimized to detect a range of model analyte concentrations using straightforward design rules and a mathematical model. Finally, we re-engineer our whole-cell biosensor for the detection of a medically relevant biomarker by the display of two different nanobodies against human fibrinogen and demonstrate a detection limit as low as 10 pM in diluted human plasma. Overall, we demonstrate that our agglutination technology fulfills the requirement of POC testing by combining low-cost nanobody production, customizable detection range and low detection limits. This technology has the potential to produce affordable diagnostics for field-testing in the developing world, emergency or disaster relief sites, as well as routine medical testing and personalized medicine., We would like to thank the following funding sources: EPSRC EP/K038648/1 (K.M.P. and P.S.F.); BBSRC CASE Studentship (N.K.); Royal Thai Government Scholarship,6 MICIU/ AEI/FEDER, EU BIO2017-89081R (L.A.F.); EPSRC EP/ P009352/1 and EP/M002187/1 (G.-B.V.S.); Imperial College President’s PhD Scholarship.18
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeted bacterial conjugation mediated by synthetic cell-to-cell adhesions

  • Robledo, Marta
  • Álvarez, Beatriz
  • Cuevas, Ana
  • González, Sheila
  • Ruano-Gallego, David
  • Fernández, Luis Ángel
  • Cruz, Fernando de la
Genetic interventions on microbiomes, for clinical or biotechnological purposes, remain challenging. Conjugation-based delivery of genetic cargo is still unspecific and limited by low conjugation rates. Here we report an approach to overcome these problems, based on a synthetic bacterial adhesion system. Mating assemblers consist on a synthetic adhesion formed by the expression on the surface of donor and target cells of specific nanobodies (Nb) and their cognate antigen (Ag). The Nb–Ag bridge increased 1–3 logs transfer of a variety of plasmids, especially in liquid media, confirming that cell-cell docking is a main determinant limiting mating efficiency. Synthetic cell-to-cell adhesion allows efficient conjugation to targeted recipients, enhancing delivery of desired genes to a predefined subset of prey species, or even specific pathogenic strains such as enterohemorrhagic Escherichia coli (EHEC), within a bacterial community. The synthetic conjugation enhancer presented here optimizes plasmid delivery by selecting the target hosts with high selectivity., Spanish Science and Innovation Ministry (MCIN) [PID2020-117923GB-I00 to F.d.l.C.]; MCIN/AEI and FEDER [BIO2017-89081-R]; MCIN/AEI and NextGeneration EU/PRTR [PLEC2021-007739 to L.A.F.]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Development of genetic circuits and synthetic receptors in Escherichia coli for detecting tumor-associated metabolites and protein antigens

  • Ceballos Munuera, Álvaro
Tesis presentada por D. Álvaro Ceballos Munuera para optar al grado de Doctor en Biociencias Moleculares por la Universidad Autónoma de Madrid (Facultad de Ciencias, Departamento de Biología Molecular, Programa de Doctorado en Biociencias Moleculares)., [EN] Anaerobic and facultative bacteria are promising tools in the treatment of cancer since they are able to colonize solid tumors, proliferating in the tumor microenvironment characterized by hypoxic and immunosuppressive conditions, with metabolite gradients that differ from healthy homeostatic concentrations. Due to their active motility, bacteria can also reach tumor regions that cannot be accessed by passive therapeutics. With the advances in synthetic biology, researchers are engineering bacteria to produce different proteins with cytotoxic and immunomodulatory activities within the tumor. In order to increase the safety of bacterial therapies the induction of these activities requires specificity to avoid enacting their effects outside the tumor. In this PhD thesis we have aimed to develop inductions systems that avoid relying in classical chemical inducers and focus on detecting specific tumor cues such as tumor-associated metabolites and proteins, as well as genetic circuit tools to program a more specific response to those signals. We have characterized several promoters that respond to increased concentrations of L-lactate, reactive oxygen species and nitric oxide (NO), which are common characteristic of the tumor microenvironment. Promoters were analyzed by using gfp as reporter gene while integrated in the chromosome of E. coli K-12, with two NO promoters (PnorV and Phmp) showing good characteristics for in vivo applications and a L-lactate promoter (a mutated version of PlldP) presenting promising results that could be further improved. Next, we tested the possibility of using serine integrases to design genetic logic circuits and generate genetic memory using targets placed in the chromosome of E. coli. We found that three different serine integrases (Bxb1, Tp901 and Int7) can successfully catalyze the excision and inversion of chromosome-integrated targets, with excision appearing more efficient. Bxb1 and Tp901 targets were used to produce functional AND logic circuits based on excision or inversion. The NO-responsive Phmp promoter and Bxb1 were used to create a NO biosensor E. coli that generates genetic memory after exposure, with all the genetic elements integrated in the chromosome of E. coli. Detection of tumor-associated proteins could also allow the specific activation of therapeutic bacteria. Previous works from our laboratory engineered E. coli cell surface display systems based on protein fusions between single-domain antibodies (nanobodies) and the b-barrel domain of outer membrane proteins (OMPs) belonging to the type V secretion system (T5SS). Building from those results, in this work we engineered different types of chimeric OMP receptors, based on the b-barrel of T5SS proteins such as intimin, invasin and EhaA, which simultaneously display a nanobody on the bacterial cell surface and protein fragments of a reporter system in the bacterial periplasm. We obtained functional chimeric proteins that display a nanobody binding the human epidermal growth factor receptor (EGFR), a tumor-associated antigen, and that express in the periplasm the two fragments of a split luciferase reporter (NanoBiT) or peptides for covalent protein fusions (SpyTag and SnoopTag). By co-expressing intiminand invasin-based chimeric receptors having the anti-EGFR nanobody and the NanoBiT fragments, we have demonstrated that E. coli bacteria can function as a biosensor, decreasing its bioluminescence signal in the presence of soluble EGFR and in a dosedependent manner. Given the modularity of these chimeric proteins, these results open the way to generate bacterial antigen receptors (BAR) for biosensors detecting multiple extracellular protein antigens associated to human diseases (infection, inflammation, cancer) as well as the presence of toxins and pathogens in environmental samples., [ES] Las bacterias anaeróbicas y facultativas son prometedoras herramientas en el tratamiento del cáncer dada su capacidad para colonizar tumores sólidos, proliferando en un microambiente tumoral caracterizado por condiciones hipóxicas e inmunosupresoras y gradientes de metabolitos que difieren de las concentraciones homeostáticas sanas. Debido a su movilidad activa, las bacterias también son capaces de alcanzar regiones tumorales a las que las terapias pasivas no pueden acceder. Gracias a los avances en biología sintética, se están diseñando bacterias capaces de producir diferentes proteínas con actividades citotóxicas e inmunomoduladoras desde el interior del tumor. Para incrementar la seguridad de las terapias bacterianas la inducción de estas actividades requiere una alta especificidad que evite que sus efectos puedan manifestarse fuera del tumor. En la presente tesis doctoral hemos trabajado en el desarrollo de sistemas de inducción que eviten la necesidad de utilizar inductores químicos clásicos y en cambio se basen en la detección de señales específicas del tumor, como son la presencia de altos niveles de metabolitos y proteínas asociadas al ambiente tumoral. Además, también se han desarrollado circuitos genéticos destinados a programar una respuesta más específica a dichas señales. En primer lugar, caracterizamos promotores que responden a altas concentraciones de L-lactato, especies reactivas de oxígeno y óxido nítrico (NO), características comunes del microambiente tumoral. Los promotores fueron analizados usando gfp como gen reportero estando integrados en el cromosoma de E. coli K-12. Dos promotores sensibles a NO (PnorV and Phmp) demostraron buenas características para su uso en aplicaciones in vivo y un promotor sensible a L-lactato (una versión mutada de PlldP) presentó resultados prometedores que podrían ser mejorados en el futuro. A continuación, estudiamos la posibilidad de usar serin-integrasas para diseñar circuitos genéticos lógicos y generar memoria genética usando dianas situadas en el cromosoma de E. coli. Determinamos que tres serin-integrasas distintas (Bxb1, Tp901 y Int7) pueden catalizar la excisión e inversión de dianas integradas en el cromosoma, con una mayor eficiencia en el caso de la excisión. Empleando dianas para Bxb1 y Tp901 se diseñaron circuitos lógicos tipo AND funcionales basados tanto en la excisión como en la inversión. Mediante el control de la expresión de Bxb1 por el promotor sensible a NO Phmp se generó una cepa de E. coli biosensora de NO que genera memoria genética tras la exposición a dicha molécula, con todos los componentes genéticos integrados en el cromosoma de la bacteria. La detección de proteínas asociadas a tumores también podría permitir una activación especifica de bacterias terapéuticas. En trabajos previos de nuestro laboratorio se diseñaron sistemas de presentación en la membrana de E. coli basados en fusiones proteicas entre anticuerpos de dominio único (nanoanticuerpos o nanobodies) y el dominio barril  de proteínas de membrana externa (OMPs) pertenecientes al sistema de secreción tipo V (T5SS). Partiendo de estos resultados, en este trabajo hemos generado diferentes tipos de receptores basados en OMP quiméricas utilizando el dominio barril  de proteínas del T5SS como intimina, invasina y EhaA, capaces de presentar simultáneamente un nanoanticuerpo en la superficie bacteriana y un fragmento proteico de un sistema reportero en el periplasma bacteriano. Se produjeron proteínas quiméricas funcionales que presentan un nanoanticuerpo capaz de unirse al factor de crecimiento epidérmico humano (EGFR), un antígeno asociado a tumores, y que expresan en el periplasma los fragmentos complementarios del sistema reportero NanoBiT, basado en una luciferasa fragmentada, o los péptidos de los sistemas SpyTag y SnoopTag, que permiten fusiones covalentes a otras proteínas. Mediante la expresión simultánea de los receptores quiméricos basados en intimina e invasina con el nanoanticuerpo contra EGFR y los fragmentos de NanoBiT hemos demostrado que la bacteria E. coli puede funcionar como un biosensor, disminuyendo su señal bioluminiscente en la presencia de EGFR soluble de manera dosis-dependiente. Dada la naturaleza modular de estas proteínas quiméricas, estos resultados abren la puerta a generar receptores bacterianos de antígeno (BAR, bacterial antigen receptors) para la creación de biosensores capaces de detectar múltiples proteínas extracelulares asociadas a enfermedades humanas (infecciones, inflamación, cáncer) así como la presencia de toxinas y patógenos en muestras ambientales., Este trabajo ha sido realizado en el Departamento de Biotecnología Microbiana del Centro Nacional de Biotecnología del Consejo Superior de Investigaciones Científicas (CNB-CSIC), gracias al contrato de Formación de Profesorado Universitario FPU16/01427 y a la financiación de los proyectos BIO2017-89081-R (AEI/MINECO), H2020 FET Open 965018- BIOCELLPHE (Unión Europea) y PLEC2021-007739 (MICIN - Líneas estratégicas), así como la ayuda Research and Training Grant FEMS-GO-2020-249 (FEMS)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A tuneable genetic switch for tight control of tac promoters in Escherichia coli boosts expression of synthetic injectisomes

  • Asensio-Calavia, Alejandro
  • Ceballos-Munuera, Álvaro
  • Méndez-Pérez, Almudena
  • Álvarez, Beatriz
  • Fernández, Luis Ángel
Biosafety of engineered bacteria as living therapeutics requires a tight regulation to control the specific delivery of protein effectors, maintaining minimum leakiness in the uninduced (OFF) state and efficient expression in the induced (ON) state. Here, we report a three repressors (3R) genetic circuit that tightly regulates the expression of multiple tac promoters (Ptac) integrated in the chromosome of E. coli and drives the expression of a complex type III secretion system injectisome for therapeutic protein delivery. The 3R genetic switch is based on the tetracycline repressor (TetR), the non-inducible lambda repressor cI (ind-) and a mutant lac repressor (LacIW220F) with higher activity. The 3R switch was optimized with different protein translation and degradation signals that control the levels of LacIW220F. We demonstrate the ability of an optimized switch to fully repress the strong leakiness of the Ptac promoters in the OFF state while triggering their efficient activation in the ON state with anhydrotetracycline (aTc), an inducer suitable for in vivo use. The implementation of the optimized 3R switch in the engineered synthetic injector E. coli (SIEC) strain boosts expression of injectisomes upon aTc induction, while maintaining a silent OFF state that preserves normal growth in the absence of the inducer. Since Ptac is a commonly used promoter, the 3R switch may have multiple applications for tight control of protein expression in E. coli. In addition, the modularity of the 3R switch may enable its tuning for the control of Ptac promoters with different inducers., Future and Emerging Technologies, Grant/Award Number: FET Open 965018-BIOCELLPHE; MCIN/AEI and NextGeneration EU/ PRTR, Grant/Award Number: PLEC2021-007739; Ministerio de Ciencia e Innovación, Grant/ Award Number: BIO2017-89081-R; PhD contracts, Grant/Award Number: FPI BES-2015-073850, FPU16/01427 and FPU18/03199, Peer reviewed